We are recruiting a highly motivated PhD student to join our translational Alzheimer’s disease research group at Karolinska Institutet, investigating novel disease mechanisms and therapeutic targets in neurodegeneration.
https://t.co/8HPR5fJRxu
I’m thrilled to announce I have been awarded an @alzassociation grant for
my ongoing research into exploring brain-specific enzyme SPPL2b’s role in AD. With this funding, I aim to identify in SPPL2b a new potential therapeutic target. #ENDALZ#ALZFunded
New pupplication from ou lab: The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice https://t.co/N3dn5MISI8 #mdpibiology via @Biology_MDPI
Signal Peptide Peptidase-Like 2b affects APP cleavage and exhibits a biphasic Aβ-mediated expression in Alzheimer's disease. https://t.co/r2T5ZbP9u0 #bioRxiv